Schmidt H, Hjorth N, Salde L
J Int Med Res. 1981;9(3):236-8. doi: 10.1177/030006058100900316.
In a double-blind within-patient clinical trial in psoriasis, budesonide 0.025% ointment has been shown to be at least as efficient as betamethasone-17-valerate 0.1% ointment. A lower concentration of budesonide ointment, 0.01%, was used for 4 weeks of maintenance treatment. This concentration controlled residual symptoms well in a majority of the patients, thirty-two in number.
在一项针对银屑病患者的双盲临床试验中，已证明0.025%的布地奈德软膏与0.1%的倍他米松-17-戊酸酯软膏疗效相当。在为期4周的维持治疗中使用了浓度更低的0.01%布地奈德软膏。该浓度在大多数（32名）患者中很好地控制了残留症状。
